Arizona Tribune - Boulevard

NYSE - LSE

CMSC	-0.02%	22.06	$
GSK	1.79%	52.02	$
BTI	0.84%	61.91	$
BCE	-0.41%	23.105	$
AZN	1.21%	185.262	$
RYCEF	3.4%	18.8	$
RBGPF	0%	61.3	$
CMSD	-0.69%	21.87	$
JRI	0.59%	12.645	$
BCC	1.45%	78.8	$
NGG	0.58%	83.315	$
VOD	0.25%	13.845	$
RIO	1.16%	95.13	$
BP	0.01%	37.864	$
RELX	-0.16%	31.1	$

Featured

US Supreme Court hands win to Bayer in weedkiller litigation

The US Supreme Court sided with multinational giant Bayer on Thursday, overturning a lower court ruling that exposed the company to thousands of claims that the Monsanto weedkiller Roundup causes cancer.

HRW denounces Turkey arrests ahead of NATO summit

Human Rights Watch on Thursday denounced Turkey's arrest of over 200 people ahead of the NATO summit in Ankara, saying it showed a "ruthless intolerance" of freedom of speech and assembly.

Last news

How a privately owned city in Kenya took on corrupt officials

To many, Tatu City on the outskirts of Nairobi looks like a success.

Australian mushroom murder suspect rejected help preparing meal: witness

An Australian woman accused of murdering three people with a toxic mushroom-laced lunch rejected offers of help before serving the dish, the sole guest to survive the deadly meal told a court on Tuesday.

Prayers, pride in Philippine papal contender's hometown

Philippine Cardinal Luis Antonio Tagle may be one of the favourites to be named the next pope, but a Catholic Sister who has known him for half a century says she will never pray for it to happen.

Mosaic Announces First Quarter 2025 Results

TAMPA, FL / ACCESS Newswire / May 6, 2025 / The Mosaic Company (NYSE:MOS) released its financial results for the first quarter of 2025. The company's earnings release and supplemental materials are available at https://investors.mosaicco.com/financials/quarterly-results.

Mosaic Biosciences Launches Neptunion in China

TAMPA, FL / ACCESS Newswire / May 6, 2025 / The Mosaic Company (NYSE:MOS) is advancing its strategy to redefine growth, and is proud to announce a successful biostimulant product launch in China. Neptunion is our newest biostimulant product - it helps crops address abiotic pressures such as drought, salinity and heat by adding stress resistant properties into water soluble fertilizers. Our Mosaic Biosciences product line offers sustainable ag technology to enable growers to improve yields while minimizing environmental impacts.

Protagonist Reports First Quarter 2025 Financial Results and Provides Corporate Update

Positive top line results from rusfertide Phase 3 VERIFY trial in polycythemia vera (PV) announced; full data selected for oral presentation during plenary session at ASCO on June 1stConference call to be held June 2nd at 8AM EDT to discuss rusfertide data presented at ASCOFull dataset from Phase 3 ICONIC-LEAD trial with icotrokinra in patients with moderate-to-severe plaque psoriasis (PsO) presented at the 2025 AAD Meeting in March; data from adolescent subset presented at World Congress of Pediatric Dermatology in AprilPositive top line results from icotrokinra Phase 2b ANTHEM trial in moderately to severely active ulcerative colitis (UC) announced in March, data to be presented at medical conference later in 2025Cash, cash equivalents and marketable securities of $697.9 million as of March 31, 2025, anticipated to provide cash runway through at least end of 2028

The Dixie Group 2025 Q1 Earnings Release and Conference Call

DALTON, GA / ACCESS Newswire / May 6, 2025 / You are invited to participate in a conference call with the management of THE DIXIE GROUP, INC (OTCQB:DXYN) regarding results for 2025 First Quarter Earnings Release on Friday, May 9, 2025, at 10:00 a.m. Eastern Time.

CannapharmaRx Continues into New European Market with First Shipment Completed to Germany

CALGARY, AB / ACCESS Newswire / May 6, 2025 / CannaPharmaRX, Inc. (OTC PINK:CPMD), a future leader in cannabis cultivation, is pleased to share recent updates, including its latest cultivation activities and sales achievements.

Electronic Caregiver Launches First-Ever AI-Powered Virtual Care Ecosystem Featuring Interactive Avatar, Now Available via Athenahealth’s EHR Network

Addison Care delivers the industry's most comprehensive AI-enabled chronic care platform - offering vitals monitoring, automated wellness checks, caregiver support, and integrated TeleCare services - now accessible to thousands of clinics through Athenahealth's nationwide EHR ecosystem.

Biofrontera Inc. to Report First Quarter FY 2025 Financial Results on May 15, 2025

WOBURN, MA / ACCESS Newswire / May 6, 2025 / Biofrontera Inc. (Nasdaq:BFRI) ("Biofrontera" or the "Company"), a biopharmaceutical company specializing in the commercialization of dermatological products, announces it will report financial results for the three months ended March 31, 2025 on Thursday, May 15, 2025. The results will be released after the market close on Thursday, May 15 and the company will host a conference call on Friday, May 16 at 10:00am Eastern Time.

Introducing the New SHELLPHA Series Ergonomic Mice, Designed for Comfort and Connectivity for a Modern Workspace

The new SHELLPHA series features multi-device connectivity with Bluetooth and USB wireless for a cleaner, more connected workspace.

SOHM, Inc., Unveils Genetically Engineered Ovarian Cancer Cell Line Using ABBIE(TM) Platform to Accelerate GYS1 Drug Discovery

CHINO HILLS, CALIFORNIA / ACCESS Newswire / May 6, 2025 / SOHM, Inc. (OTC PINK:SHMN), a biotech company at the forefront of precision cellular engineering, announced today the successful development of a genetically modified ovarian cancer cell line (SKOV3) overexpressing the GYS1 gene, using its proprietary gene editing platform, ABBIE™. This breakthrough establishes a powerful tool for the rapid screening of novel glycogen synthase 1 (GYS1) inhibitors and underscores SOHM's capacity to swiftly generate custom-engineered cell models to support targeted drug development.

Clarity Clinic Expands PHP/IOP Mental Health Services to Arlington Heights, Bringing Specialized Care to the Northwest Suburbs

New Adult and Adolescent Programs Launching in May and June to Improve Access to Structured Mental Health Support

Sunshine Biopharma Launches Generic Lurasidone for Schizophrenia in the Canadian Sector of the Global $1.2 Billion Market

FORT LAUDERDALE, F / ACCESS Newswire / May 6, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that its wholly owned Canadian subsidiary, Nora Pharma Inc., has launched Lurasidone, a new generic prescription drug in the therapeutic class of antipsychotics.

Xifaxan(R) (rifaximin) Treatment Following Overt Hepatic Encephalopathy (OHE) Hospitalization Associated with Reduced Risk of 30-Day OHE Rehospitalization

New analysis suggests efficacy of Xifaxan to mitigate OHE rehospitalizations irrespective of treatment history

CBD Life Sciences Inc. (CBDL) Announces New Manufacturing Deal With A Southwest-Based Company

Strategic alliance positions CBDL for aggressive national growth through 100+ retail locations and new premium product lines

SafeHeal(R) Closes Oversubscribed €35 Million Series C Equity Financing

Financing led by Solar Eclipse with new investors Gideon Strategic Partners and M&L Healthcare, part of M&L Group, and returning investors Sofinnova Partners and one of the largest Multinational life sciences corporations from a strategic standpoint.Proceeds will support the completion of SafeHeal's IDE pivotal study and preparation for commercial launch of their lead technology, Colovac®.

MIRA Pharmaceuticals Reports No Brain Toxicity in FDA-Required Study of Ketamir-2, Confirming Absence of Ketamine-Linked Neurotoxicity

Preclinical data supports the advancement of oral Ketamir-2 as a safe, next-generation alternative to ketamine, with ongoing momentum in Phase I clinical trial enrollment

Global Survey Reveals Urgent Gaps in Awareness, Access, and Treatment for Hepatitis D

LONDON, UK / ACCESS Newswire / May 6, 2025 / A new report released today by the World Hepatitis Alliance (WHA) reveals widespread knowledge gaps, inequities in access, and critical systemic barriers impeding the global fight against hepatitis delta.

FBC Holding, Inc. (FBCD) Expands Retail Footprint With Two Flagship Locations In Arizona's Top Shopping Destinations

SCOTTSDALE, AZ / ACCESS Newswire / May 6, 2025 / FBCD (OTC PINK:FBCD) is proud to announce a bold new leap in its expansion strategy, officially opening two premium retail locations at Chandler Fashion Center (3111 W Chandler Blvd, Chandler, AZ 85226) and SanTan Village (2218 E Williams Field Rd, Gilbert, AZ 85295). These launches position FBCD's retail presence at the heart of Arizona's most trafficked and trend-forward shopping destinations, reinforcing its growing dominance in the luxury streetwear and lifestyle market.

Boditech Med and SphingoTec Announce Launch of AFIAS penKid(R) Assay for Kidney Function Diagnostics

Boditech Med and SphingoTec announce the launch of the AFIAS sphingotest® penKid® assay, a diagnostic tool designed to aid in kidney function assessment for critically ill patients.The IVDR-marked assay provides quantitative measurements of Proenkephalin A 119-159 (penKid), supporting clinical decision-making in acute and critical care.This launch follows a licensing agreement granting Boditech the rights to develop and commercialize penKid-based assays, as well as a market development agreement between the two companies.

Evotec SE Reports Q1 2025 results: Paving the Way for 2025 Growth in Soft Market Environment

Group revenues of € 200 m, on track towards guidance; Shared R&D with similar trend as 2024; Just - Evotec Biologics with continuing growth momentumStrong progress in strategic protein degradation partnership with Bristol Myers SquibbStrategy building on technology and science leadership: Focus on high-growth, high-value segments, simplifying the business model and fostering operational excellence2025 Guidance and 2028 Outlook confirmed

Cardinals assemble to elect pope and set course for church

All 133 Catholic cardinals who will vote for a new pope have arrived in Rome, the Vatican said Monday, two days before they gather in conclave to elect the next head of the world's 1.4 billion Catholics.

French court backs Olympics choreographer in cyberbullying case

A French court on Monday found seven people guilty of bullying the chief choreographer of last year's Paris Olympics opening ceremony online, handing down fines and suspended prison terms.

Cassocks competition: whose outfit will new pope wear?

For decades, one Rome tailor has been making the white cassock new popes don immediately after election -- but this conclave it has competition.

Catholic Church's direction in the balance as conclave looms

Catholic cardinals will enter into conclave this week to choose a new pope, with the Church's 1.4 billion members holding their breath over an uncertain outcome.

Trump orders rebuilding and reopening of defunct US prison Alcatraz

US President Donald Trump said Sunday he had directed officials to rebuild and reopen Alcatraz prison, the notorious federal jail based on a small island in California that closed six decades ago.

Forte Group Announces Filing of Fiscal 2024 Audited Financial Statements

VANCOUVER, BC / ACCESS Newswire / May 5, 2025 / Forte Group Holdings Inc. (CSE:FGH)(OTC:FGHFF)(FSE:7BC0, WKN:A40L1Z)("Forte Group" or the "Company"), a diversified lifestyle and wellness consumer packaged goods company, announces that, further to its news release dated May 1, 2025, it has completed and filed its audited financial statements for the fiscal year ended December 31, 2024, including the accompanying management's discussion and analysis and CEO and CFO certifications (collectively, the "Required Filings").

NHI Announces Second Quarter 2025 Dividend

MURFREESBORO, TN / ACCESS Newswire / May 5, 2025 / National Health Investors, Inc. (NYSE:NHI) announced today that it will pay its second quarter dividend of $0.90 per common share on August 1, 2025, to stockholders of record as of June 30, 2025.

NHI Announces First Quarter 2025 Results

MURFREESBORO, TN / ACCESS Newswire / May 5, 2025 / National Health Investors, Inc. (NYSE:NHI) announced today its results for the three months ended March 31, 2025.

New to The Street Expands Broadcast Reach to Middle East, Adding 26 Million Homes Across Bloomberg Television

New distribution begins June 2025, supporting the IPOMarket.com and MarketWear™ segments as sponsored programming

USGS Challenges Simple Narrative Linking Menhaden to Osprey Decline

Federal agency finds complex ecological causes behind osprey trends, not single-species blame

Arizona Tribune - Boulevard (English)